Potthoff, Alexander https://orcid.org/0000-0002-5452-7700
Schwenzfeier, Jan https://orcid.org/0000-0002-0795-2405
Niehaus, Marcel https://orcid.org/0000-0002-4876-6190
Bessler, Sebastian https://orcid.org/0000-0002-0377-1164
Hoffmann, Emily https://orcid.org/0000-0002-0958-6699
Soehnlein, Oliver https://orcid.org/0000-0002-7854-0694
Höhndorf, Jens
Dreisewerd, Klaus https://orcid.org/0000-0002-7619-808X
Soltwisch, Jens https://orcid.org/0000-0002-0258-1561
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (544444139)
Deutsche Forschungsgemeinschaft (449437943)
Deutsche Forschungsgemeinschaft (449437943)
Article History
Received: 11 June 2025
Accepted: 23 September 2025
First Online: 15 October 2025
Competing interests
: The authors declare the following competing interest(s): MN and JH are employees of Bruker Daltonik GmbH & Co KG (Bremen). KD, MN, AP, and JS have patents pending regarding parts of the hardware development (WO/2024/041681, WO/2025/067576). O.S. receives funds from Novo Nordisk and consults Novo Nordisk and Roche. Parts of this research have been funded by Bruker Daltonik GmbH & Co KG by supplying hardware, software, and salaries for AP and JSch. The remaining authors declare no competing interests.